IART Insider Trading

Insider Ownership Percentage: 3.54%
Insider Buying (Last 12 Months): $1,499,742.09
Insider Selling (Last 12 Months): $41,072.00

Integra LifeSciences Insider Trading History Chart

This chart shows the insider buying and selling history at Integra LifeSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1M$0$1MTotal Insider BuyingTotal Insider Selling

Integra LifeSciences Share Price & Price History

Current Price: $13.51
Price Change: Price Decrease of -0.16 (-1.17%)
As of 05/13/2025 05:00 PM ET

This chart shows the closing price history over time for IART up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarAprMay$13.51Closing price on 05/13/25:

SEC Filings (Institutional Ownership Changes) for Integra LifeSciences (NASDAQ:IART)

84.78% of Integra LifeSciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IART by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$34Mbought$3.57MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$500M$0$500MTotal InflowsTotal Outflows
Integra LifeSciences logo
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Read More on Integra LifeSciences

Today's Range

Now: $13.51
Low: $13.02
High: $13.77

50 Day Range

MA: $18.59
Low: $12.25
High: $23.95

52 Week Range

Now: $13.51
Low: $11.60
High: $32.66

Volume

1,254,323 shs

Average Volume

1,044,361 shs

Market Capitalization

$1.05 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27

Who are the company insiders with the largest holdings of Integra LifeSciences?

Integra LifeSciences' top insider investors include:
  1. Stuart Essig (Chairman)
  2. Michael J Mcbreen (EVP)
  3. Witte Jan De (CEO)
Learn More about top insider investors at Integra LifeSciences.

Who are the major institutional investors of Integra LifeSciences?

Integra LifeSciences' top institutional investors include:
  1. Vanguard Group Inc. — 9.73%
  2. Assenagon Asset Management S.A. — 2.33%
  3. Lord Abbett & CO. LLC — 1.71%
  4. Charles Schwab Investment Management Inc. — 1.48%
  5. Bank of New York Mellon Corp — 0.57%
  6. Principal Financial Group Inc. — 0.56%
Learn More about top institutional investors of Integra LifeSciences stock.

Which institutional investors are selling Integra LifeSciences stock?

During the last quarter, IART stock was sold by these institutional investors:
  1. Vanguard Group Inc.
  2. State of Alaska Department of Revenue
  3. Olstein Capital Management L.P.
  4. Russell Investments Group Ltd.
  5. Bank of New York Mellon Corp
  6. Leeward Investments LLC MA
  7. Rhumbline Advisers
  8. New York State Teachers Retirement System

Which institutional investors are buying Integra LifeSciences stock?

Within the previous quarter, IART stock was acquired by institutional investors including:
  1. Assenagon Asset Management S.A.
  2. Nuveen LLC
  3. Victory Capital Management Inc.
  4. Charles Schwab Investment Management Inc.
  5. Allianz Asset Management GmbH
  6. Tejara Capital Ltd
  7. Public Sector Pension Investment Board
  8. Federated Hermes Inc.
Within the last year, these company insiders have bought Integra LifeSciences stock:
  1. Stuart Essig (Chairman)
  2. Michael J Mcbreen (EVP)
Learn More investors buying Integra LifeSciences stock.